US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 4.390
- +0.330+8.13%
Close May 3 16:00 ET
- 4.410
- +0.020+0.46%
Post 18:47 ET
3.08BMarket Cap11.55P/E (TTM)
4.500High4.060Low1.86MVolume4.080Open4.060Pre Close8.11MTurnover2.54%Turnover RatioLossP/E (Static)701.98MShares5.22052wk High69.68P/B321.89MFloat Cap1.50052wk Low--Dividend TTM73.32MShs Float19.750Historical High--Div YieldTTM10.84%Amplitude0.660Historical Low4.354Avg Price1Lot Size
About Summit Therapeutics Company
Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolSMMT
Company NameSummit Therapeutics
Listing DateMar 5, 2015
Founded2004
CEOMr. Robert W. Duggan
MarketNASDAQ
Employees105
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address136a Eastern Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4SB
Phone44-1235-443939
Websitehttp://summitplc.com
Company Executives
- Name
- Position
- Salary
- Robert W. Duggan
- Non-Executive Director,Chairman and Chief Executive Officer
- --
- Rainer M. Erdtmann
- Non-Executive Director
- --
- Dr. Elaine Carla Stracker
- Executive Director
- --
- Manmeet Singh Soni
- Non-Executive Director
- --
- Glyn Owain Edwards MBE
- Non-Executive Director
- --
- Dr. Ventzislav Kirilov Stefanov
- Executive Director
- --
- Melissa Strange
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg